Accessible at-home COVID-19 tests are designed with visually impaired, blind individuals in mind

Article

These new testing kits permit more equitable access to coronavirus testing.

A newly designed at-home COVID-19 test kit creates accessibility for individuals with visual impairments or blindness. These free testing kits are available through the US government.

These especially designed kits satisfy a need in which blind and visually impaired population cannot use standard rapid COVID-19 test kits on their own, and are designed with this patient population in mind, according to Ashish Jha, MD, MPH, the White House Response Coordinator.

The Administration for Community Living explained that 12 test kits are provided in each order; Medicare will provide up to 8 more tests each month. The recipients of the test kits must have a Bluetooth-enabled smartphone; a free app can be downloaded that provides audible instructions and the test results.

Individuals can contact the Disability Information and Access Line for help.

Patients are invited to call 1-800-232-0233 or order the tests online through the US Postal Service and COVIDTest.gov.

Jha commented that the newly designed test kit “ensures that everyone has equitable access to COVID-19 testing and all other critical…mitigation strategies is of the utmost importance.”

Reference
1. Suran M. Free COVID-19 tests for people with visual impairment. JAMA. 2022;328:699. doi:10.1001/jama.2022.14205

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Mitch Ibach, OD, FAAO, details a presentation he gave with Tanner Ferguson, MD, at the Collaborative Care Symposium 2025.
Mitch Ibach, OD, FAAO, details the importance of identifying the best candidates and practicing comanagement for refractive surgery.
Mark Bullimore, MCOptom, PhD, details the importance of preparing optometric students for myopic patient care in a Collaborative Care Symposium (CCS) 2025 presentation.
Peter Hersh, MD, stated that the key takeaway from a handful of presentations he gave at CCS 2025 is that successfully treating patients with keratoconus is identifying the disease early.
Susana Marcos, PhD, discusses the implications her research presents for the role optical coherence tomography (OCT) could play in presbyopia and myopia accommodation efforts.
Susana Marcos, PhD, outlines a presentation she gave at ARVO 2025 on a unique utilization of optical coherence tomography.
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
At CIME 2025, Selina McGee, OD, FAAO, says some patients underestimate oculoplastic care. She stands in front of a sign that says Controversies in Modern Eye Care 2025.
Rhue and Canto-Sims talk the value of contact lens patients, financial insights, and key benefits of implementing a contact lens management system.
Drs Brianna Rhue and Diana Canto-Sims discuss the benefits of implementing a contact lens management system that can help improve lens sales at your practice.
© 2025 MJH Life Sciences

All rights reserved.